arrow
A

Amanda Winters

national institute of standards and technology
H指数:20
被引数:3,537

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A single-cell multi-omics assay for simultaneous measurement of vector copy number and protein expression in CAR T cells

单细胞多组学方法用于CAR T细胞中载体拷贝数和蛋白质表达的同步测量

2026-05-010
OAAI
Targeting Acute Myeloid Leukemia Stem Cells through Perturbation of Mitochondrial Calcium
2024-05-231
OA
Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine

通过数字聚合酶链反应评估的多基因可测量的残留疾病在接受维奈托克/阿扎胞苷的急性髓性白血病患者中具有临床和生物学效用

2023-12-143
OAAI
A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy
2023-06-2631
OA
Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia
2023-04-1311
OAAI
Outcomes Are Similar After Allogeneic Hematopoietic Stem Cell Transplant for Newly Diagnosed Acute Myeloid Leukemia Patients who Received Venetoclax plus Azacitidine Versus Intensive Chemotherapy

接受维奈托克联合阿扎胞苷与强化化疗的新诊断急性髓系白血病患者异基因造血干细胞移植后的结果相似

2022-10-0117
OAAI
Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells
2020-11-01153
OAAI
Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia
2020-04-01304
OAAI
Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia
2019-10-16124
OA